124 related articles for article (PubMed ID: 3012779)
1. Calcium modulation activates Epstein-Barr virus genome in latently infected cells.
Faggioni A; Zompetta C; Grimaldi S; Barile G; Frati L; Lazdins J
Science; 1986 Jun; 232(4757):1554-6. PubMed ID: 3012779
[TBL] [Abstract][Full Text] [Related]
2. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
Williams MV; Holliday J; Glaser R
Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
Lin JC; Smith MC
Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
[TBL] [Abstract][Full Text] [Related]
4. Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patients.
Stewart JP; McGown AT; Prendiville J; Pettit GR; Fox BW; Arrand JR
Cancer Chemother Pharmacol; 1993; 33(1):89-91. PubMed ID: 8269596
[TBL] [Abstract][Full Text] [Related]
5. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
8. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
Miller CL; Lee JH; Kieff E; Longnecker R
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
[TBL] [Abstract][Full Text] [Related]
9. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
10. Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication.
Lin JC; Smith MC; Pagano JS
Virology; 1982 Feb; 117(1):186-94. PubMed ID: 6278735
[No Abstract] [Full Text] [Related]
11. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.
Clarke PA; Sharp NA; Arrand JR; Clemens MJ
Biochim Biophys Acta; 1990 Aug; 1050(1-3):167-73. PubMed ID: 2169891
[TBL] [Abstract][Full Text] [Related]
13. Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells.
Sundar SK; Ablashi DV; Armstrong GR; Zipkin M; Faggioni A; Levine PH
Int J Cancer; 1981 Oct; 28(4):503-7. PubMed ID: 6273335
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-induced early polypeptides in Raji and NC37 cells activated by diterpene ester TPA in combination with N-butyrate.
Kawanishi M; Sugawara K; Ito Y
Virology; 1981 Dec; 115(2):406-9. PubMed ID: 6274093
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus induction by a serum factor. Purification of a high molecular weight protein that is responsible for induction.
Bauer G; Höfler P; Simon M
J Biol Chem; 1982 Oct; 257(19):11405-10. PubMed ID: 6288682
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a DNase induced by Epstein-Barr virus.
Tan RS; Datta AK; Cheng YC
J Virol; 1982 Dec; 44(3):893-9. PubMed ID: 6294337
[TBL] [Abstract][Full Text] [Related]
17. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
Grogan E; Jenson H; Countryman J; Heston L; Gradoville L; Miller G
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1332-6. PubMed ID: 3029778
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional transcription of the Epstein-Barr virus major internal repeat.
Rogers RP; Speck SH
J Virol; 1990 May; 64(5):2426-9. PubMed ID: 1691315
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase.
Sixbey JW; Pagano JS
J Virol; 1985 Jan; 53(1):299-301. PubMed ID: 2981351
[TBL] [Abstract][Full Text] [Related]
20. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.
Weigel R; Miller G
Virology; 1983 Mar; 125(2):287-98. PubMed ID: 6301144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
